Plus Therapeutics Inc (NASDAQ:PSTV) has a beta value of 0.38 and has seen 3.22 million shares traded in the last trading session. The company, currently valued at $13.67M, closed the last trade at $1.16 per share which meant it lost -$0.36 on the day or -23.68% during that session. The PSTV stock price is -130.17% off its 52-week high price of $2.67 and 79.31% above the 52-week low of $0.24. If we look at the company’s 10-day average daily trading volume, we find that it stood at 45.99 million shares traded. The 3-month trading volume is 16.13 million shares.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Sporting -23.68% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PSTV stock price touched $1.16 or saw a rise of 34.46%. Year-to-date, Plus Therapeutics Inc shares have moved 0.87%, while the 5-day performance has seen it change -1.69%. Over the past 30 days, the shares of Plus Therapeutics Inc (NASDAQ:PSTV) have changed 71.85%. Short interest in the company has seen 0.93 million shares shorted with days to cover at 0.04.
Plus Therapeutics Inc (PSTV) estimates and forecasts
The company’s shares have lost -24.68% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 11.32%.
3 analysts offering their estimates for the company have set an average revenue estimate of 1.48M for the current quarter. 3 have an estimated revenue figure of 1.52M for the next ending quarter. Year-ago sales stood 1.68M and 1.28M respectively for this quarter and the next, and analysts expect sales will shrink by -11.55% for the current quarter and 11.32% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 48.41% over the past 5 years. Earnings growth for 2025 is a modest 83.76% while over the next 5 years, the company’s earnings are expected to increase by 48.21%.
PSTV Dividends
Plus Therapeutics Inc is expected to release its next earnings report on 2025-Mar-26 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders
Insiders own 17.36% of the company shares, while shares held by institutions stand at 11.50% with a share float percentage of 13.92%. Investors are also buoyed by the number of investors in a company, with Plus Therapeutics Inc having a total of 11.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Jan 31, 2025 , the former fund manager holds about 0.29% shares in the company for having 34.43 shares of worth $39942.0 while later fund manager owns 32.54 shares of worth $37747.0 as of Dec 31, 2024 , which makes it owner of about 0.28% of company’s outstanding stock.
